Nucleus Drugs Private Limited Company Logo

Nucleus Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2005.

2005 | Hyderabad, Telangana, India | Struck Off
Last Updated:

About Nucleus Drugs Private Limited

Nucleus Drugs Private Limited, a struck off private limited company, was established on 21 December 2005 in Hyderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230TG2005PTC048507. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Gorla Srinivasa Reddy (Director), Dodda Sridhar Kumar (Director). Its latest AGM occurred on 26 September 2008, with the balance sheet filed on 31 March 2008. It is based at Sh No: 337, Padmavathi Plaza, Kphb Colony, Hyderabad, Telangana, 500072.

Company Details

  • CIN/LLPIN

    U24230TG2005PTC048507

  • Registration Number

    048507

  • Incorporation Date

    21 December 2005

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 20 Year, 6 Days
  • Last Filing with ROC 31 Mar 2008
Company report

Nucleus Drugs Private Limited

Company Report FY 2025-2026

Explore comprehensive insights into Nucleus Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element

Who are the key members and board of directors at Nucleus Drugs Private Limited?

Current Directors

NameDesignationAppointment DateStatus
Gorla Srinivasa ReddyDirector21 Dec 2005Current
Dodda Sridhar KumarDirector21 Dec 2005Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nucleus Drugs.

Enhance accessibility to Nucleus Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nucleus Drugs revenue growth over time
Nucleus Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Nucleus Drugs?

Unlock access to Nucleus Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

There are no open charges registered against the company as per our records.

How Many Employees Work at Nucleus Drugs?

Unlock and access historical data on people associated with Nucleus Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Nucleus Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nucleus Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleus Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Nucleus Drugs

Recent Activity within the Organization

  • Annual General Meeting

    The activity Nucleus Drugs Private Limited last Annual general meeting of members was held on 26 Sep 2008 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Nucleus Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2008 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Gorla Srinivasa Reddy was appointed as a Director was appointed as a Director on 21 Dec 2005 & has been associated with this company since 20 years 6 days . was documented.

  • Director Appointment

    Progress on Dodda Sridhar Kumar was appointed as a Director was appointed as a Director on 21 Dec 2005 & has been associated with this company since 20 years 6 days . was documented.

  • Company Incorporation

    Nucleus Drugs Private Limited was registered on 21 Dec 2005 with Roc Hyderabad & aged 20 years 6 days as per MCA records. was recorded as a recent event.

Frequently Asked Questions

  • What is the CIN of Nucleus Drugs Private Limited?

    The CIN of Nucleus Drugs Private Limited is U24230TG2005PTC048507.

  • Where is Nucleus Drugs Private Limited headquartered?

    Nucleus Drugs Private Limited is headquartered at Sh No: 337, Padmavathi Plaza, Kphb Colony, Hyderabad, Telangana, 500072.

  • When was Nucleus Drugs Private Limited incorporated?

    Nucleus Drugs Private Limited was incorporated on 21 December 2005.

  • Who are the current directors of Nucleus Drugs Private Limited?

    The current directors of Nucleus Drugs Private Limited are

  • What is the primary industry of Nucleus Drugs Private Limited?

    The primary industry of Nucleus Drugs Private Limited is Chemicals.

  • Is Nucleus Drugs Private Limited a listed company?

    Nucleus Drugs Private Limited is unlisted.

  • What is the capital structure of Nucleus Drugs Private Limited?

    The authorized capital of Nucleus Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial